SEC Filings - Marker Therapeutics, Inc.

Filing date	Form	Description	View
Aug 8, 2018	8-K	Report of unscheduled material events or corporate event	0001144204-18-042861.pdf 0001144204-18-042861.rtf 0001144204-18-042861.xls View HTML
Jul 13, 2018	PREM14A	A preliminary proxy statement relating to a merger or acquisition	0001144204-18-038363.pdf 0001144204-18-038363.rtf 0001144204-18-038363.xls View HTML
Jun 21, 2018	424B7	424B7	0001144204-18-035109.pdf 0001144204-18-035109.rtf 0001144204-18-035109.xls View HTML
Jun 15, 2018	424B7	424B7	0001144204-18-034436.pdf 0001144204-18-034436.rtf 0001144204-18-034436.xls View HTML
Jun 8, 2018	8-K	Report of unscheduled material events or corporate event	0001144204-18-033374.pdf 0001144204-18-033374.rtf 0001144204-18-033374.xls View HTML
May 24, 2018	D		0001144204-18-030789.pdf 0001144204-18-030789.rtf View HTML
May 18, 2018	8-K	Report of unscheduled material events or corporate event	0001144204-18-029884.pdf 0001144204-18-029884.rtf 0001144204-18-029884.xls View HTML
May 16, 2018	SC 13D/A	An amendment to a SC 13D filing	0001408408-18-000005.pdf 0001408408-18-000005.rtf 0001408408-18-000005.xls View HTML
May 16, 2018	4	Statement of changes in beneficial ownership of securities	0001408408-18-000007.pdf 0001408408-18-000007.rtf View HTML
May 15, 2018	8-K	Report of unscheduled material events or corporate event	0001144204-18-028370.pdf 0001144204-18-028370.rtf 0001144204-18-028370.xls View HTML

Data provided by Kaleidoscope.